Deals Rumor Mill: Frontier-Suzhou, VF Corp., SIG Combibloc
A pair of Chinese drug developers are looking to join in on a growing trend of biotech public offerings in Hong Kong, Bloomberg reported on Friday. Citing anonymous sources, it said...To view the full article, register now.
Already a subscriber? Click here to view full article